Well-Mama Community Doula Navigator Study

Sponsor
Northwestern University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05179369
Collaborator
Woman's Hospital, Louisiana (Other), Rutgers University (Other), Cook County Health & Hospitals System (Other)
576
2
36

Study Details

Study Description

Brief Summary

This study will develop and test an intervention, called the Well-Mama intervention, which includes the use of a checklist by Community Doula Navigators to support pregnant women. Participants will be randomized to either receive standard perinatal care or standard perinatal care plus the Well-Mama intervention.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Standard Care with Well-Mama Intervention
N/A

Detailed Description

Black, Indigenous, and People of Color (BIPOC) women experience profound maternal health disparities in the US, including rising rates of maternal mortality and severe maternal morbidity. This study will develop a Well-Mama intervention for pregnant and postpartum BIPOC women, centered around Community Doula Navigators conducting in-person and telehealth check-ins on 5 priority areas (mental health, cardiovascular symptoms, safety, opioid/substance abuse, and social support), supplemented with virtual support groups and labor support. The investigators will conduct a randomized trial to test whether the Well-Mama intervention increases BIPOC women's receipt of prenatal and postpartum care.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
576 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Hybrid Type 1 randomized effectiveness-implementation trialHybrid Type 1 randomized effectiveness-implementation trial
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Enhancing Perinatal Care Support to Improve Maternal Mortality Disparities
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Dec 31, 2025
Anticipated Study Completion Date :
Dec 31, 2025

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Standard Care

Participants randomized to standard care will be offered prenatal and postpartum care in accordance with site-specific procedures based on AAP and ACOG Guidelines for Perinatal Care. The initial intake appointment, involving a comprehensive visit with physical exam, medical and psychosocial history, laboratory testing, and education would optimally occur in the 1st trimester. Subsequent prenatal visits, per ACOG, is monthly for the first 28 weeks, biweekly for weeks 28-36, and weekly after 36 weeks. More frequent visits may be offered to women at high risk. In addition, some sites may offer supports such as nutritional counseling, childbirth education, and case management. A comprehensive postpartum care visit would typically occur within the first 6 weeks of birth, involving a physical examination, lab tests, and immunizations.

Experimental: Standard Care with Well-Mama Intervention

Participants will receive standard perinatal care plus the Well Mama intervention, including the Well Mama Checklist, assistance from a Community Doula Navigator, and virtual support groups.

Behavioral: Standard Care with Well-Mama Intervention
The intervention involves: (1) a Well-Mama checklist on 5 topic areas aligned with leading causes of MM and SMM: (a) mental health/depression; (b) cardiovascular symptoms; (c) safety (e.g., guns at home and intimate partner violence); (d) opioid/substance abuse; and (e) social support, self-agency, and well-being; and (2) Community Doula Navigators (CDNs) who will: (a) conduct biweekly check-ins with pregnant and postpartum women using the Well-Mama List and make appropriate referrals to providers and other resources following check-ins; (b) attend select patient visits; (c) lead virtual pregnancy & postpartum support groups; and (d) provide labor support.

Outcome Measures

Primary Outcome Measures

  1. Number of Recommended Perinatal Care Components Received [Baseline through 1 year postpartum]

    The primary outcome will be a composite proportion of perinatal care components across three domains, including prenatal care, postpartum care, and social determinants of health content compared between participants in the intervention and control arms.

Secondary Outcome Measures

  1. Level of patient engagement in healthcare management [Baseline through 1 year postpartum]

    Patients will complete surveys to measure their level of engagement in their healthcare management .

  2. Level of self-efficacy for dealing with stressful situations [Baseline through 1 year postpartum]

    Patients will complete surveys to measure their level of self-efficacy for dealing with stressful situations.

  3. Level of trust in health care system [Baseline through 1 year postpartum]

    Patients will complete surveys to measure their level of trust with the health care system.

  4. Rate of experiences of racism and discrimination [Baseline through 1 year postpartum]

    Patients will complete surveys to measure their perceived experiences of racism and discrimination while getting health care.

  5. Number of participants with low birth weight newborns [Baseline through 1 year postpartum]

    Medical record data extraction will include the number of participants with low birth weight newborns.

  6. Number of participants with NICU admissions [Baseline through 1 year postpartum]

    Medical record data extraction will include the number of participants with deliveries resulting in NICU admissions.

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years to 49 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Pregnant individuals that are age 15-49 years; (2) uninsured or have public insurance (i.e., Medicaid); (3) singleton pregnancy <32 weeks gestation; and (4) not cognitively impaired
Exclusion Criteria:

Already receiving/enrolled in another perinatal care program beyond standard care, such as group prenatal care, maternity home, or employing their own doula

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Northwestern University
  • Woman's Hospital, Louisiana
  • Rutgers University
  • Cook County Health & Hospitals System

Investigators

  • Principal Investigator: Melissa A Simon, MD, MPH, Center for Health Equity Transformation Northwestern University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Melissa Simon, Vice Chair of Research, Professor of Obstetrics and Gynecology, Northwestern University
ClinicalTrials.gov Identifier:
NCT05179369
Other Study ID Numbers:
  • MD016280
First Posted:
Jan 5, 2022
Last Update Posted:
Feb 25, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Feb 25, 2022